在临床试验中,估计从终止维持生命治疗中产生的偏差
Clifton W Callaway1,2, Jonathan Elmer3, Peter J Kudenchuk4
1University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. callawaycw@upmc.edu.
Critical care (London, England)
|July 9, 2025
概括
在临床试验中停止维持生命治疗 (WLST) 可能会导致结果偏差. 本研究引入了一种方法来识别和量化这种偏差,提供更清晰的治疗效果估计.
科学领域:
- 关键护理医学 关键护理医学
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
背景情况:
- 在重症患者中,停止维持生命治疗 (WLST) 是常见的,通常在医院死亡之前.
- 在临床试验中,WLST作为随机化后干预措施,可能会影响治疗效果的估计.
- 目前的试验分析很少考虑WLST对结果的影响.
研究的目的:
- 开发一种系统的方法来分析临床试验中的WLST率和相关的参与者特征.
- 为了确定WLST引入的偏差,并执行灵敏度分析以限制其大小和方向.
- 提供一种方法来估计在假设没有WLST的情况下治疗效应.
主要方法:
- 分析临床试验数据中的WLST率和参与者人口统计数据.
- 实施灵敏度分析以量化来自WLST的潜在偏差.
- 将拟议的方法应用于医院外心脏骤停治疗的随机试验.
主要成果:
- 该研究在心脏骤停试验中发现了可归因于WLST的偏差,这减少了观察到的治疗效果.
- 灵敏度分析成功地限制了偏差,允许估计没有WLST的假设治疗效应.
- 拟议的方法增强了对受WLST影响的临床试验结果的解释.
结论:
- 在临床试验分析中考虑WLST对于准确估计治疗效果至关重要.
- 开发的系统方法和灵敏度分析为偏见评估提供了有价值的工具.
- 这种方法为试验结果提供了更好的洞察力,特别是在WLST常见的重症监护机构.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
217
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
180
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
180
02:07Blind Procedures
12.2K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.2K
01:24Kaplan-Meier Approach
276
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
276
01:11Blinding
2.7K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.7K
01:20Actuarial Approach
138
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
138
01:15Assumptions of Survival Analysis
199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199